These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28834146)
21. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials. Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498 [TBL] [Abstract][Full Text] [Related]
22. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [TBL] [Abstract][Full Text] [Related]
23. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance. Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107 [TBL] [Abstract][Full Text] [Related]
24. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis. Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351 [TBL] [Abstract][Full Text] [Related]
25. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis. Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272 [TBL] [Abstract][Full Text] [Related]
26. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399 [TBL] [Abstract][Full Text] [Related]
27. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice. Zhao C; Nguyen MH J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266 [TBL] [Abstract][Full Text] [Related]
28. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360 [TBL] [Abstract][Full Text] [Related]
29. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients. Lee HW; Ahn SH World J Gastroenterol; 2016 Oct; 22(37):8314-8321. PubMed ID: 27729738 [TBL] [Abstract][Full Text] [Related]
30. Adherence to a Semiannual Surveillance Program for Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Mancebo A; González-Diéguez ML; Navascués CA; Cadahía V; Varela M; Pérez R; Rodrigo L; Rodríguez M J Clin Gastroenterol; 2017 Jul; 51(6):557-563. PubMed ID: 27775957 [TBL] [Abstract][Full Text] [Related]
31. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol. Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722 [TBL] [Abstract][Full Text] [Related]
32. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Kansagara D; Papak J; Pasha AS; O'Neil M; Freeman M; Relevo R; Quiñones A; Motu'apuaka M; Jou JH Ann Intern Med; 2014 Aug; 161(4):261-9. PubMed ID: 24934699 [TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis and hepatocellular carcinoma. Marrero CR; Marrero JA Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352 [TBL] [Abstract][Full Text] [Related]
34. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Amarapurkar D; Han KH; Chan HL; Ueno Y; J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082 [TBL] [Abstract][Full Text] [Related]
35. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562 [TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community. Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478 [TBL] [Abstract][Full Text] [Related]
37. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360 [TBL] [Abstract][Full Text] [Related]
38. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada. Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234 [TBL] [Abstract][Full Text] [Related]
39. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression? D'Ambrosio R; Colombo M Liver Int; 2016 Jun; 36(6):783-90. PubMed ID: 26936383 [TBL] [Abstract][Full Text] [Related]
40. Current Practice of Hepatocellular Carcinoma Surveillance. Loho IM; Siregar L; Waspodo AS; Hasan I Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]